Converge Bio

Converge Bio is an AI-native company in Biotechnology. Shown below: 1 funding round.

AI-native Not profitable Featured: —

$150M

Listed valuation

Visit website

Figures and classifications reflect imported catalog records, not live company reporting.

Funding rounds

1 round

Series A Announced 13 Jan 2026 · Leads: Bessemer Venture Partners

$25M Raised $25M Round 4 investors Announced

Imported positions; not an independent quality score.